Evidence map›Paper›PMID 34091740›Full record

ArticleRheumatology international2021

Resilience in women with primary Sjögren's syndrome.

Roberta Priori, Federico Giardina, Raffaella Izzo, Angelica Gattamelata, Massimo Fusconi, Serena Colafrancesco, Giuseppe Curcio

Abstract read
PubMed Publisher
In one paragraph

Article in Rheumatology international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Sjögren's disease, occupational performance and quality of life.The British journal of occupational therapy · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Resilience and its correlates in patients with narcolepsy type 1.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Roberta PrioriDepartment of Clinical, Internal, Anesthetic and Cardiovascular Science-Rheumatology Unit, Azienda Ospedaliera Universitaria Policlinico Umberto I, Sapienza University of Rome, viale del Policlinico 155, 00161, Rome, Italy. r.priori@policlinicoumberto1.it.ORCID http://orcid.org/0000-0002-6695-1445
Federico GiardinaDepartment of Clinical, Internal, Anesthetic and Cardiovascular Science-Rheumatology Unit, Azienda Ospedaliera Universitaria Policlinico Umberto I, Sapienza University of Rome, viale del Policlinico 155, 00161, Rome, Italy.ORCID http://orcid.org/0000-0002-9613-8391
Raffaella IzzoDepartment of Clinical, Internal, Anesthetic and Cardiovascular Science-Rheumatology Unit, Azienda Ospedaliera Universitaria Policlinico Umberto I, Sapienza University of Rome, viale del Policlinico 155, 00161, Rome, Italy.ORCID http://orcid.org/0000-0003-1626-2868
Angelica GattamelataDepartment of Clinical, Internal, Anesthetic and Cardiovascular Science-Rheumatology Unit, Azienda Ospedaliera Universitaria Policlinico Umberto I, Sapienza University of Rome, viale del Policlinico 155, 00161, Rome, Italy.ORCID http://orcid.org/0000-0003-1541-5973
Massimo FusconiDepartment of Oral and Maxillo-Facial Surgery, Sapienza University of Rome, Rome, Italy.ORCID http://orcid.org/0000-0002-0546-7051
Serena ColafrancescoDepartment of Clinical, Internal, Anesthetic and Cardiovascular Science-Rheumatology Unit, Azienda Ospedaliera Universitaria Policlinico Umberto I, Sapienza University of Rome, viale del Policlinico 155, 00161, Rome, Italy.ORCID http://orcid.org/0000-0001-7802-1192
Giuseppe CurcioDepartment of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
Policlinico Umberto I · ITSapienza University of Rome · ITUniversity of L'Aquila · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To assess the relationship between resilience and several diseases and individual features in primary Sjӧgren's Syndrome (SS) patients. Resilience was assessed using the Resilience Scale (RS-14). Disease activity, damage, and reported symptoms were assessed by means of ESSDAI (EULAR Sjögren's syndrome disease activity index), SSDDI (Sjӧgren's Syndrome Disease Damage Index) and ESSPRI (EULAR Sjӧgren's Syndrome Patient Reported Index). EuroQol, HADS (Hospital Anxiety and Depression Scale), SF-12 (Short-form 12 health survey), FAS (Fatigue Assessment Scale), FACIT-F (Functional Assessment of Chronic Illness Therapy - Fatigue), and IPAQ (International Physical Activity Questionnaire) questionnaires were submitted to evaluate physical and mental well-being of the recruited patients. Data about the autoimmune profile, systemic manifestations, and current therapy were collected. Educational qualifications and work activities were also considered. Descriptive, correlational, and linear regression analysis were performed. 74 consecutive women with primary SS and 74 sex and age-matched healthy subjects as a control group were recruited. SS patients displayed a moderate value of resilience (median 78.5) with no significant difference compared to controls (p = 0.38). An inverse relationship was found between resilience and mood disorders such as anxiety (p = 0.038) and depression (p < 0.001). Greater resilience was associated with a better perception of the quality of life (p = 0.02) and general health (p < 0.001), as well as with less fatigue (p = 0.008) and a more physically active lifestyle (p = 0.001). No significant relationship was found neither between resilience and age, socio-demographic and disease characteristics, nor with ESSDAI (p = 0.26), ESSPRI (p = 0.83) and SSDDI (p = 0.67). This is the first study assessing resilience in a large group of unselected primary SS patients. Most resilient primary SS patients are less depressed and show a better perception of their health. Greater resilience tends to correlate with less anxiety, physical and mental fatigue, and a more active lifestyle, while no association with disease activity and duration, damage, and socio-demographic features was detected. Considering the well-known role of resilience in helping to better cope with chronic illnesses, its assessment in SS patients should not be overlooked and the possible strategies for its improvement should be better explored and further implemented.

Indexed as

Resilience, PsychologicalAdultAgedAged, 80 and overAnxietyCross-Sectional StudiesDepressionFatigueFemaleHumansItalyMiddle AgedQuality of LifeSjogren's SyndromeSurveys and QuestionnairesFatigue Assessment Scale (FAS)Mood disordersResilienceSjögren’s syndrome

Identifiers

PMID34091740
OpenAlexW3170946632

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.